Malaysia · Delayed Price · Currency is MYR KLSE:HSPLANT Statistics
Total Valuation
KLSE:HSPLANT has a market cap or net worth of MYR 1.98 billion. The enterprise value is 1.27 billion.
| Market Cap | 1.98B |
| Enterprise Value | 1.27B |
Important Dates
The next estimated earnings date is Tuesday, September 1, 2026.
| Earnings Date | Sep 1, 2026 |
| Ex-Dividend Date | Sep 9, 2026 |
Share Statistics
KLSE:HSPLANT has 799.69 million shares outstanding.
| Current Share Class | 799.69M |
| Shares Outstanding | 799.69M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 11.93% |
| Float | 211.54M |
Valuation Ratios
The trailing PE ratio is 15.02 and the forward PE ratio is 11.04. KLSE:HSPLANT's PEG ratio is 1.53.
| PE Ratio | 15.02 |
| Forward PE | 11.04 |
| PS Ratio | 2.61 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 10.85 |
| P/OCF Ratio | 7.67 |
| PEG Ratio | 1.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.34, with an EV/FCF ratio of 6.97.
| EV / Earnings | 9.65 |
| EV / Sales | 1.67 |
| EV / EBITDA | 4.34 |
| EV / EBIT | 6.24 |
| EV / FCF | 6.97 |
Financial Position
The company has a current ratio of 11.07, with a Debt / Equity ratio of 0.03.
| Current Ratio | 11.07 |
| Quick Ratio | 9.96 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.39 |
| Interest Coverage | 61.00 |
Financial Efficiency
Return on equity (ROE) is 6.31% and return on invested capital (ROIC) is 10.76%.
| Return on Equity (ROE) | 6.31% |
| Return on Assets (ROA) | 4.94% |
| Return on Invested Capital (ROIC) | 10.76% |
| Return on Capital Employed (ROCE) | 8.01% |
| Weighted Average Cost of Capital (WACC) | 3.15% |
| Revenue Per Employee | 95,512 |
| Profits Per Employee | 16,566 |
| Employee Count | 7,968 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 5.25 |
Taxes
In the past 12 months, KLSE:HSPLANT has paid 39.63 million in taxes.
| Income Tax | 39.63M |
| Effective Tax Rate | 23.09% |
Stock Price Statistics
The stock price has increased by +24.00% in the last 52 weeks. The beta is -0.20, so KLSE:HSPLANT's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | +24.00% |
| 50-Day Moving Average | 2.42 |
| 200-Day Moving Average | 2.26 |
| Relative Strength Index (RSI) | 50.71 |
| Average Volume (20 Days) | 216,390 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:HSPLANT had revenue of MYR 761.04 million and earned 132.00 million in profits. Earnings per share was 0.17.
| Revenue | 761.04M |
| Gross Profit | 280.99M |
| Operating Income | 203.93M |
| Pretax Income | 171.63M |
| Net Income | 132.00M |
| EBITDA | 266.16M |
| EBIT | 203.93M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 781.69 million in cash and 71.91 million in debt, with a net cash position of 709.78 million or 0.89 per share.
| Cash & Cash Equivalents | 781.69M |
| Total Debt | 71.91M |
| Net Cash | 709.78M |
| Net Cash Per Share | 0.89 |
| Equity (Book Value) | 2.13B |
| Book Value Per Share | 2.66 |
| Working Capital | 808.57M |
Cash Flow
In the last 12 months, operating cash flow was 258.41 million and capital expenditures -75.65 million, giving a free cash flow of 182.76 million.
| Operating Cash Flow | 258.41M |
| Capital Expenditures | -75.65M |
| Depreciation & Amortization | 62.22M |
| Net Borrowing | -13.12M |
| Free Cash Flow | 182.76M |
| FCF Per Share | 0.23 |
Margins
Gross margin is 36.92%, with operating and profit margins of 26.80% and 17.34%.
| Gross Margin | 36.92% |
| Operating Margin | 26.80% |
| Pretax Margin | 22.55% |
| Profit Margin | 17.34% |
| EBITDA Margin | 34.97% |
| EBIT Margin | 26.80% |
| FCF Margin | 24.01% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.97%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 2.97% |
| Dividend Growth (YoY) | -35.20% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 46.04% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.97% |
| Earnings Yield | 6.66% |
| FCF Yield | 9.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for KLSE:HSPLANT is 2.90, which is 16.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2.90 |
| Price Target Difference | 16.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 6.39% |
| EPS Growth Forecast (3Y) | 8.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:HSPLANT has an Altman Z-Score of 4.03 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.03 |
| Piotroski F-Score | 4 |